172 related articles for article (PubMed ID: 14668694)
21. Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
De Ridder L; Van Dieren JM; Van Deventer HJ; Stokkers PC; Van der Woude JC; Van Vuuren AJ; Benninga MA; Escher JC; Hommes DW
Aliment Pharmacol Ther; 2006 Apr; 23(8):1137-41. PubMed ID: 16611274
[TBL] [Abstract][Full Text] [Related]
22. Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease.
Hindorf U; Lyrenäs E; Nilsson A; Schmiegelow K
Scand J Gastroenterol; 2004 Nov; 39(11):1105-12. PubMed ID: 15545169
[TBL] [Abstract][Full Text] [Related]
23. Paradoxical elevated thiopurine S-methyltransferase activity after pancytopenia during azathioprine therapy: potential influence of red blood cell age.
de Boer NK; van Bodegraven AA; de Graaf P; van der Hulst RW; Zoetekouw L; van Kuilenburg AB
Ther Drug Monit; 2008 Jun; 30(3):390-3. PubMed ID: 18520612
[TBL] [Abstract][Full Text] [Related]
24. Azathioprine, 6-mercaptopurine and thiopurine S-methyltransferase.
Roberts-Thomson IC; Butler WJ
J Gastroenterol Hepatol; 2005 Jun; 20(6):955. PubMed ID: 15946151
[No Abstract] [Full Text] [Related]
25. Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center.
Banerjee S; Bishop WP
J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):324-30. PubMed ID: 16954954
[TBL] [Abstract][Full Text] [Related]
26. Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.
Fargher EA; Tricker K; Newman W; Elliott R; Roberts SA; Shaffer JL; Bruce I; Payne K
J Clin Pharm Ther; 2007 Apr; 32(2):187-95. PubMed ID: 17381669
[TBL] [Abstract][Full Text] [Related]
27. [Thiopurine methyltransferase activity and myelosuppression in inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine].
Gisbert JP; Luna M; Maté J; González-Guijarro L; Cara C; Pajares JM
Med Clin (Barc); 2003 Jun; 121(1):1-5. PubMed ID: 12812701
[TBL] [Abstract][Full Text] [Related]
28. Genotyping should be considered the primary choice for pre-treatment evaluation of thiopurine methyltransferase function.
Hindorf U; Appell ML
J Crohns Colitis; 2012 Jul; 6(6):655-9. PubMed ID: 22398041
[TBL] [Abstract][Full Text] [Related]
29. Azathioprine-associated acute myeloid leukemia in a patient with Crohn's disease and thiopurine S-methyltransferase deficiency.
Yenson PR; Forrest D; Schmiegelow K; Dalal BI
Am J Hematol; 2008 Jan; 83(1):80-3. PubMed ID: 17696202
[TBL] [Abstract][Full Text] [Related]
30. Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine.
Sparrow MP; Hande SA; Friedman S; Lim WC; Reddy SI; Cao D; Hanauer SB
Aliment Pharmacol Ther; 2005 Sep; 22(5):441-6. PubMed ID: 16128682
[TBL] [Abstract][Full Text] [Related]
31. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
Cao Q; Zhu Q; Shang Y; Gao M; Si J
Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
[TBL] [Abstract][Full Text] [Related]
32. Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease.
Hindorf U; Lindqvist M; Hildebrand H; Fagerberg U; Almer S
Aliment Pharmacol Ther; 2006 Jul; 24(2):331-42. PubMed ID: 16842460
[TBL] [Abstract][Full Text] [Related]
33. Two cases of thiopurine methyltransferase (TPMT) deficiency--a lucky save and a near miss with azathioprine.
Gardiner SJ; Gearry RB; Barclay ML; Begg EJ
Br J Clin Pharmacol; 2006 Oct; 62(4):473-6. PubMed ID: 16995868
[TBL] [Abstract][Full Text] [Related]
34. Review article: thiopurines in inflammatory bowel disease.
Derijks LJ; Gilissen LP; Hooymans PM; Hommes DW
Aliment Pharmacol Ther; 2006 Sep; 24(5):715-29. PubMed ID: 16918876
[TBL] [Abstract][Full Text] [Related]
35. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.
Su C; Lichtenstein GR
Gastroenterol Clin North Am; 2004 Jun; 33(2):209-34, viii. PubMed ID: 15177535
[TBL] [Abstract][Full Text] [Related]
36. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations.
Al Hadithy AF; de Boer NK; Derijks LJ; Escher JC; Mulder CJ; Brouwers JR
Dig Liver Dis; 2005 Apr; 37(4):282-97. PubMed ID: 15788214
[TBL] [Abstract][Full Text] [Related]
37. [Thiopurine methyltransferase activity in inflammatory bowel disease. A study on 7046 Spanish patients].
Gisbert JP; Gomollón F; Cara C; Luna M; González-Lama Y; Pajares JM; Maté J; Guijarro LG
Med Clin (Barc); 2005 Sep; 125(8):281-5. PubMed ID: 16159550
[TBL] [Abstract][Full Text] [Related]
38. Optimizing thiopurine therapy in inflammatory bowel disease.
Chevaux JB; Peyrin-Biroulet L; Sparrow MP
Inflamm Bowel Dis; 2011 Jun; 17(6):1428-35. PubMed ID: 20949566
[TBL] [Abstract][Full Text] [Related]
39. A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
Dubinsky MC; Reyes E; Ofman J; Chiou CF; Wade S; Sandborn WJ
Am J Gastroenterol; 2005 Oct; 100(10):2239-47. PubMed ID: 16181376
[TBL] [Abstract][Full Text] [Related]
40. Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease.
Ansari A; Arenas M; Greenfield SM; Morris D; Lindsay J; Gilshenan K; Smith M; Lewis C; Marinaki A; Duley J; Sanderson J
Aliment Pharmacol Ther; 2008 Oct; 28(8):973-83. PubMed ID: 18616518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]